| SDAX P-IN. | 12,071.36 / +0.16% |
News
- PTA-News: S&T AG: S&T AG DEFIES THE CORONAVIRUS CRISIS WITH A SUCCESSFUL Q2
07:00 - pressetext - Jungheinrich AG Extends Global Technology Agreement with PowerFleet
07/13/2020 / 14:00 - GlobeNewswire - PTA-News: Medigene AG: Medigene announces dosing of first patient in Phase I/II trial with TCR therapy MDG1011 for various blood cancers
02/26/2019 / 12:36 - pressetext - PTA-Adhoc: Medigene AG: Medigene announces dosing of first patient in Phase I/II trial with TCR therapy MDG1011 for various blood cancers
02/26/2019 / 12:35 - pressetext - PTA-News: Medigene AG: Medigene presents development strategies for TCR therapies at CAR-TCR Summit Europe
02/26/2019 / 07:30 - pressetext - PTA-News: Medigene AG: European Patent covering TCR library suitable for the development of neoantigen-specific TCRs
02/25/2019 / 07:30 - pressetext - PTA-News: Medigene AG: Medigene participates at upcoming conferences
02/22/2019 / 07:30 - pressetext - PTA-News: Medigene AG: Medigene appoints Axel-Sven Malkomes as CFO/CBDO
02/11/2019 / 07:30 - pressetext - PTA-News: Medigene AG: Medigene participates at four upcoming conferences
01/17/2019 / 07:30 - pressetext - PTA-News: Medigene AG: Additional European patent granted for Medigene's DC vaccine platform
01/08/2019 / 17:35 - pressetext - PTA-Adhoc: Medigene AG: Medigene publishes topline interim data from ongoing Phase I/II clinical trial with DC vaccines in AML patients
12/19/2018 / 21:40 - pressetext - PTA-News: Medigene AG: Medigene participates at further upcoming conferences
12/18/2018 / 07:30 - pressetext - PTA-News: Medigene AG: Medigene participates at further upcoming conferences
11/20/2018 / 07:30 - pressetext - PTA-Adhoc: Medigene AG: Medigene Signs Exclusive License Agreement with Leiden University to Develop Novel T Cell Receptor
11/12/2018 / 18:50 - pressetext - PTA-News: Medigene AG: Medigene participates at four conferences in November
10/31/2018 / 07:30 - pressetext
Real-time